Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Liver Diseases

  Free Subscription


23.07.2018

1 Biochem Biophys Res Commun
2 Dig Dis
1 Dig Dis Sci
3 Eur Radiol
1 Gastrointest Endosc
3 Gut
10 Hepatology
1 Indian J Gastroenterol
1 J Gastroenterol
2 PLoS One
1 Proc Natl Acad Sci U S A
1 Radiology
2 Transplantation


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Biochem Biophys Res Commun

  1. CHEN Z, Xu J, Wu Y, Lei S, et al
    Diosgenin inhibited the expression of TAZ in hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2018 Jul 11. pii: S0006-291X(18)31517.
    PubMed     Text format     Abstract available


    Dig Dis

  2. BUTTERWORTH RF, Canbay A
    Hepatoprotection by L-Ornithine L-Aspartate in Non-Alcoholic Fatty Liver Disease.
    Dig Dis. 2018 Jul 17:1-6. doi: 10.1159/000491429.
    PubMed     Text format     Abstract available

  3. LONGO L, de Freitas LBR, Santos D, Grivicich I, et al
    Sorafenib for Advanced Hepatocellular Carcinoma: A Real-Life Experience.
    Dig Dis. 2018 Jul 13:1-8. doi: 10.1159/000490378.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  4. KALIANNAN K
    Compromise of alpha-Defensin Function in Liver Cirrhosis Facilitates the Toxic Relationship Between Gut Permeability and Endotoxemia.
    Dig Dis Sci. 2018 Jul 14. pii: 10.1007/s10620-018-5197.
    PubMed     Text format    


    Eur Radiol

  5. SONG JS, Choi EJ, Park EH, Lee JH, et al
    Comparison of transient severe motion in gadoxetate disodium and gadopentetate dimeglumine-enhanced MRI: effect of modified breath-holding method.
    Eur Radiol. 2018;28:1132-1139.
    PubMed     Text format     Abstract available

  6. AKAI H, Yasaka K, Nojima M, Kunimatsu A, et al
    Gadoxetate disodium-induced tachypnoea and the effect of dilution method: a proof-of-concept study in mice.
    Eur Radiol. 2018;28:692-697.
    PubMed     Text format     Abstract available

  7. KELLER S, Sedlacik J, Schuler T, Buchert R, et al
    Prospective comparison of diffusion-weighted MRI and dynamic Gd-EOB-DTPA-enhanced MRI for detection and staging of hepatic fibrosis in primary sclerosing cholangitis.
    Eur Radiol. 2018 Jul 16. pii: 10.1007/s00330-018-5614.
    PubMed     Text format     Abstract available


    Gastrointest Endosc

  8. ROCKEY DC
    Screening for esophageal varices in patients with hepatocellular carcinoma.
    Gastrointest Endosc. 2018;88:240-241.
    PubMed     Text format    


    Gut

  9. CUSI K
    Pioglitazone for the treatment of NASH in patients with prediabetes or type 2 diabetes mellitus.
    Gut. 2018;67:1371.
    PubMed     Text format    

  10. ROTMAN Y, Sanyal AJ
    Pioglitazone for the treatment of NASH in patients with prediabetes or type 2 diabetes mellitus-authors' response.
    Gut. 2018;67:1372.
    PubMed     Text format    

  11. ASPICHUETA P
    Lipid-rich environment: a key role promoting carcinogenesis in obesity-related non-alcoholic fatty liver disease.
    Gut. 2018;67:1376-1377.
    PubMed     Text format    


    Hepatology

  12. HAIDER C, Hnat J, Wagner R, Huber H, et al
    Transforming Growth Factor-beta and Axl Induce CXCL5 and Neutrophil Recruitment in Hepatocellular Carcinoma.
    Hepatology. 2018 Jul 16. doi: 10.1002/hep.30166.
    PubMed     Text format     Abstract available

  13. NAVIN P, Hilscher M, Welle C, Mounajjed T, et al
    The Utility of MR Elastography to Differentiate Nodular Regenerative Hyperplasia from Cirrhosis.
    Hepatology. 2018 Jul 17. doi: 10.1002/hep.30175.
    PubMed     Text format     Abstract available

  14. KIM D, Li AA, Perumpail BJ, Gadiparthi C, et al
    Changing Trends in Etiology- and Ethnicity-Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States.
    Hepatology. 2018 Jul 16. doi: 10.1002/hep.30161.
    PubMed     Text format     Abstract available

  15. BARCENA-VARELA M, Caruso S, Llerena S, Alvarez-Sola G, et al
    Dual targeting of histone methyltransferase G9a and DNA-methyltransferase 1 for the treatment of experimental hepatocellular carcinoma.
    Hepatology. 2018 Jul 16. doi: 10.1002/hep.30168.
    PubMed     Text format     Abstract available

  16. ROMAN E, Gely C, Flavia M, Poca M, et al
    Patients with compensated cirrhosis are also at risk of falling.
    Hepatology. 2018 Jul 17. doi: 10.1002/hep.30180.
    PubMed     Text format     Abstract available

  17. ZHANG J, Han C, Ungerleider N, Chen W, et al
    A novel TGF-beta and H19 signaling axis in tumor-initiating hepatocytes that regulates hepatic carcinogenesis.
    Hepatology. 2018 Jul 16. doi: 10.1002/hep.30153.
    PubMed     Text format     Abstract available

  18. CINGOLANI F, Czaja MJ
    Oxidized Albumin - a Trojan Horse for p38 MAPK-Mediated Inflammation in Decompensated Cirrhosis.
    Hepatology. 2018 Jul 16. doi: 10.1002/hep.30164.
    PubMed     Text format     Abstract available

  19. VUPPALANCHI R, Mathur K, Pyko M, Samala N, et al
    Liver Stiffness Measurements in Patients with Non-cirrhotic Portal Hypertension - The Devil is In the Details.
    Hepatology. 2018 Jul 17. doi: 10.1002/hep.30167.
    PubMed     Text format     Abstract available

  20. LIAO SH, Su TH, Jeng YM, Liang PC, et al
    Clinical Manifestations and Outcomes of Patients with Sarcomatoid Hepatocellular Carcinoma.
    Hepatology. 2018 Jul 16. doi: 10.1002/hep.30162.
    PubMed     Text format     Abstract available

  21. ZHOU X, Wen Y, Tian Y, He M, et al
    Hsp90alpha-dependent Bclaf1 promotes hepatocellular carcinoma proliferation by regulating c-MYC mRNA stability.
    Hepatology. 2018 Jul 17. doi: 10.1002/hep.30172.
    PubMed     Text format     Abstract available


    Indian J Gastroenterol

  22. SHETTY S, Nagaraju SP, Shenoy S, Attur RP, et al
    Acute kidney injury in patients with cirrhosis of liver: Clinical profile and predictors of outcome.
    Indian J Gastroenterol. 2018 Jul 17. pii: 10.1007/s12664-018-0867.
    PubMed     Text format     Abstract available


    J Gastroenterol

  23. SHIMA T, Uto H, Ueki K, Kohgo Y, et al
    Hepatocellular carcinoma as a leading cause of cancer-related deaths in Japanese type 2 diabetes mellitus patients.
    J Gastroenterol. 2018 Jul 13. pii: 10.1007/s00535-018-1494.
    PubMed     Text format     Abstract available


    PLoS One

  24. JANSEN C, Al-Kassou B, Lehmann J, Pohlmann A, et al
    Severe abnormal Heart Rate Turbulence Onset is associated with deterioration of liver cirrhosis.
    PLoS One. 2018;13:e0195631.
    PubMed     Text format     Abstract available

  25. HONDA F, Hiramatsu A, Hyogo H, Aikata H, et al
    Evaluation of glycemic variability in chronic liver disease patients with type 2 diabetes mellitus using continuous glucose monitoring.
    PLoS One. 2018;13:e0195028.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  26. GENG Y, Michowski W, Chick JM, Wang YE, et al
    Kinase-independent function of E-type cyclins in liver cancer.
    Proc Natl Acad Sci U S A. 2018;115:1015-1020.
    PubMed     Text format     Abstract available


    Radiology

  27. BARR RG
    Liver Elastography Still in Its Infancy.
    Radiology. 2018;288:107-108.
    PubMed     Text format    


    Transplantation

  28. GADSDEN MM, Goldberg DS
    Hepatic Dysfunction in Deceased Donors in the Age of the Opioid Epidemic.
    Transplantation. 2018 Jul 13. doi: 10.1097/TP.0000000000002368.
    PubMed     Text format    

  29. BARBIER L, Bucur P, Salame E
    Extended-criteria allografts a strategy to reduce waiting list mortality in selected hepatocellular carcinoma recipients.
    Transplantation. 2018 Jul 13. doi: 10.1097/TP.0000000000002365.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: